Class 2 Medicines Recall: Norgine Pharmaceuticals Limited, Pedmarqsi 80 mg/mL solution for infusion, EL(26)A/42

Imported from official source

Norgine Pharmaceuticals Limited is recalling the batches listed in the table due to risk of particulate matter being present in the product identified during routine stability investigations.

This version

Version
1 of 1
Recorded
October 12, 2026 11:00
Change
Initial
Content hash
85ce04d7d1b8630751b7741d1f07a855
All versions
Revision history

Officially records where a publication came from, not whether it is true. Imported records are reproduced from an organization's own official source.